A new compound known as Lorcaserin aided many obese and overweight individuals to lose nearly 5% of their total bodyweight. This new study was published in the medical journal, “New England Journal of Medicine.” As the reduction in weight is not that much, still the drug is reputed to have very few side effects compared to other obesity drugs which looks to be more specific and effective. Read on to know more about the new drug predicted to have fewer side effects.
This new drug is developed by Arena Pharmaceuticals which is based in San Diego. This directly acts on the specific receptors subset present for chemical messenger, serotonin. The receptors are responsible for satiety, which is the feeling of complete fullness.
About the New Obesity Drug
Since the 1990s, this company has trying to develop such kind of a compound as a research established a link between the appetite and some serotonin receptors present in the brain.
According to physician Arne Astrup, University of Copenhagen, this new drug is a first of its kind tailor-made compound which targets the receptors involved in the condition of satiety. Also, it is responsible for reducing the caloric intake.
Other Obesity Drugs
Many of the drugs related to weight loss have either been taken out of the market or left in the late-stage of the development due to their dangerous and harmful side effects. A major concern among many is the long-term safety issue as previous studies indicate that in several cases such kind of drugs must be taken regularly to achieve weight loss.
According to Dr. Steven Smith, Florida Hospital, such kind of weight loss drugs work only as long as you take them. They are similar to blood-pressure or cholesterol drugs than the antibiotics, which immediately cure an infection and can altogether be stopped.
